Canada’s Right-Wing Think Tanks Love Race Science
By Mitchell Thompson,
Jacobin
| 04. 11. 2022
Photo of Charles Murray
by Gage Skidmore on Flickr
When right-wing governments across Canada slash social programs and protections, they turn to research institutes and think tanks who eagerly prepare policy papers to support them. It is this stratum of researchers and scholars who provide the ideological underpinning for conservative political strategy.
Starting in the 1970s, ongoing cuts have been made to Canada’s social assistance programs, leaving the country’s welfare net threadbare. The justifications for these cuts were often provided by right-wing think tanks who advanced the principle that the poor are innately inferior and undeserving of assistance. These rationales evince a passion for the ideas of Charles Murray and other social scientists whose policy advice hinges on racist pseudoscience. In their telling, the problems of social inequality can largely be explained by welfare mothers’ “illegitimate births” and the genetic inferiority of people of color.
A review of the proposals used by Canadian conservatives to gut social spending has found that the case made by these think tanks was based as much on a racist and classist worldview as on...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...